Merck, a leading science and technology company, and the Broad Institute of MIT and Harvard (Boston,...
TraceLink Inc., the world's largest integrated digital supply network, providing real-time information sharing for bette...
Exicure, a pioneer in gene regulatory and immunotherapeutic drugs utilizing spherical nucleic acid (SNA) constructs...
Recursion, a next-gen biopharma company combining automated, experimental biology with artificial intelligence to discov...
Illumina has announced the global expansion of Illumina Accelerator to Cambridge, United Kingdom. Founded in the Sa...
Gilead Sciences and the Renown Institute for Health Innovation (IHI) have announced a strategic collaboration to co...
Johnson & Johnson has announced that Janssen Vaccines & Prevention B.V., one of its Janssen Pharmaceutical Compa...
An injection of nanoparticles can prevent the body’s immune system from overreacting to trauma, potentially preven...
Abbott has announced that U.S. Food and Drug Administration (FDA) approval for its new blood and plasma screening Alinit...
US based Gilead Sciences and Belgian firm Galapagos have announced that they have entered into a 10-year globa...
Certara®, the global leader in model-informed drug development, regulatory science, real-world evidence and market a...
SOTIO and Cytune Pharma, members of the PPF Group have announced that the first dosing of cancer patients with ...
Celsius Therapeutics, a company focused on the discovery and development of precision therapeutics for patients with aut...
Sandoz has announced the launch of the generic oncology medicine gefitinib indicated for adult patients with locally adv...
Increasing prevalence of rare genetic disorders globally coupled with extensive applications of direct-to-consumer genet...
WHO’s Essential Medicines List and List of Essential Diagnostics are core guidance documents that help countries p...
Lyndra Therapeutics, the company making daily pills a thing of the past, has announced a partnership with Gilead Science...
ImaginAb Inc., a US based clinical stage immuno-oncology imaging company has entered into a non-exclusive license and co...
